- Home
- BOLT vs COSM Comparison
BOLT vs COSM Comparison
Compare BOLT & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOLT
- COSM
- Stock Information
- Founded
- BOLT 2015
- COSM 2009
- Country
- BOLT United States
- COSM United States
- Employees
- BOLT N/A
- COSM N/A
- Industry
- BOLT Biotechnology: Pharmaceutical Preparations
- COSM Other Pharmaceuticals
- Sector
- BOLT Health Care
- COSM Health Care
- Exchange
- BOLT Nasdaq
- COSM Nasdaq
- Market Cap
- BOLT 10.4M
- COSM 12.3M
- IPO Year
- BOLT 2021
- COSM 2013
- Fundamental
- Price
- BOLT $6.17
- COSM $1.03
- Analyst Decision
- BOLT Buy
- COSM
- Analyst Count
- BOLT 3
- COSM 0
- Target Price
- BOLT $47.50
- COSM N/A
- AVG Volume (30 Days)
- BOLT 33.8K
- COSM 1.2M
- Earning Date
- BOLT 11-11-2025
- COSM 11-13-2025
- Dividend Yield
- BOLT N/A
- COSM N/A
- EPS Growth
- BOLT N/A
- COSM N/A
- EPS
- BOLT N/A
- COSM N/A
- Revenue
- BOLT $4,167,000.00
- COSM $55,093,442.00
- Revenue This Year
- BOLT N/A
- COSM $28.14
- Revenue Next Year
- BOLT N/A
- COSM N/A
- P/E Ratio
- BOLT N/A
- COSM N/A
- Revenue Growth
- BOLT N/A
- COSM N/A
- 52 Week Low
- BOLT $4.59
- COSM $0.28
- 52 Week High
- BOLT $14.36
- COSM $1.28
- Technical
- Relative Strength Index (RSI)
- BOLT 63.23
- COSM 57.98
- Support Level
- BOLT $5.13
- COSM $0.92
- Resistance Level
- BOLT $6.20
- COSM $1.27
- Average True Range (ATR)
- BOLT 0.32
- COSM 0.11
- MACD
- BOLT 0.07
- COSM -0.01
- Stochastic Oscillator
- BOLT 87.19
- COSM 40.74
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.